The risk of developing this cancer due to MMR gene mutations is only three- to five-fold higher, and often the first clinical manifestation of the disease and the cause of death are related to colorectal cancer, which can lead to an underestimation of the incidence of PC in patients carrying germline mutations in MSH2/6 [62–64]. The gene discussed is MSH2; the disease is pachyonychia congenita.